论文信息 - Non-Pegylated Liposomal Encapsulated Doxorubicin Reduces Cardiotoxicity in 1st Line Treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Final Results of a Randomized Trial - 字舞流文

Non-Pegylated Liposomal Encapsulated Doxorubicin Reduces Cardiotoxicity in 1st Line Treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Final Results of a Randomized Trial

R. Greil | U. Jaeger | M. Fridrik | F. Keil | W. Oberaigner | W. Willenbacher | O. Krieger | A. Petzer | S. Burgstaller | A. Lang | J. Andel